Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07013864

Enrollment

Registered

2025-06-10

Start date

2024-07-01

Completion date

2024-09-30

Last updated

2025-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-Related Infections, Cross Infection, Drug Resistance, Bacterial, Infant, Newborn, Intensive Care Units, Neonatal, Sepsis, Staphylococcal Infections, Staphylococcus Haemolyticus

Brief summary

This study looks at cases of Staphylococcus haemolyticus infections in newborns hospitalized in the Neonatal Intensive Care Unit (NICU) at the Saint-Denis Hospital in 2023. Researchers reviewed the medical records of 28 infants who had this bacteria found in their blood or catheter cultures. The goal is to understand whether these infections have increased and how they affected the babies' health.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 2 Months

Inclusion criteria

* Newborns in 2023 * hospitalized in the Neonatal and Neonatal Resuscitation department of the Saint-Denis * At least one isolation of S. haemolyticus in blood cultures or catheter cultures

Exclusion criteria

\- No

Design outcomes

Primary

Measure	Time frame
Incidence of Staphylococcus haemolyticus Infections Associated with Central Venous Catheters (CVCs)	January 1, 2023 - December 31, 2023

Countries

France

Outcome results